Exome Asset Management LLC CNTA — CENTESSA PHARMACEUTICALS PLC

Ownership history in Exome Asset Management LLC  ·  7 quarters on record

AI Ownership Summary

Exome Asset Management LLC reported CENTESSA PHARMACEUTICALS PLC (CNTA) in 7 quarterly 13F filings from 2024 Q1 through 2025 Q3. Peak portfolio weight reached 2.66% in 2024 Q1. The latest visible filing shows CNTA at 1.29% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CNTA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Exome Asset Management LLC's position in CENTESSA PHARMACEUTICALS PLC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

CNTA was reported at 1.29% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
2.66% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CNTA stock page Exome Asset Management LLC fund profile Exome Asset Management LLC full holdings
How Exome Asset Management LLC held CNTA — position size vs. price
% of Fund (quarterly)    CNTA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 REDUCED 47.3% +2.2% ❌ 88,024 -78,920 -47.3% 1.29% $2.1M 2025-11-14 $27.61
2025 Q2 ADDED — — — 166,944 +24,200 +17.0% 1.63% $2.2M 2025-08-14 $17.64
2025 Q1 ADDED — — — 142,744 +5,028 +3.7% 1.82% $2.1M 2025-05-15 $12.59
2024 Q4 REDUCED — — — 137,716 -436 -0.3% 1.73% $2.3M 2025-02-14 $17.07
2024 Q3 REDUCED 49.7% +2.2% ❌ 138,152 -136,748 -49.7% 1.52% $2.2M 2024-11-14 $17.50
2024 Q2 UNCHANGED — — — 274,900 — 0% 2.16% $2.5M 2024-08-14 $12.60
2024 Q1 INITIATED — — — 274,900 — — 2.66% $3.1M 2024-05-15 $8.79

🏢 Other funds also holding CNTA

As of 2026 Q1 — sorted by position size

Index Venture Life Associates VI Ltd 3Y 100.0% Medicxi Ventures Management (Jersey) Ltd 3Y 80.76% Foresite Capital Management VI LLC 11.77% EcoR1 Capital, LLC 3Y 7Y 10.11% 5AM Venture Management, LLC 3Y 6.41% First Light Asset Management, LLC 3Y 7Y 5.56% TCG Crossover Management, LLC 3Y 4.87% Spruce Street Capital LP 4.68% Avoro Capital Advisors LLC 3Y 7Y 4.47% Logos Global Management LP 3Y 4.21%

FAQ About Exome Asset Management LLC and CNTA

These are the practical questions this page is built to answer before you even open the full history table.

How long has Exome Asset Management LLC reported owning CNTA?

Exome Asset Management LLC reported CNTA across 7 quarterly 13F filings, from 2024 Q1 through 2025 Q3.

What was the largest reported CNTA position in Exome Asset Management LLC's portfolio?

The largest reported portfolio weight for CNTA was 2.66% in 2024 Q1.

What is the latest reported CNTA position on this page?

The most recent filing on this page is 2025 Q3, when Exome Asset Management LLC reported 88,024 shares, equal to 1.29% of portfolio, with an estimated market value of $2.1M.

What does the chart on this CNTA ownership page compare?

The chart compares Exome Asset Management LLC's quarterly CNTA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Exome Asset Management LLC time their CNTA position?

Based on 13F filing dates vs. subsequent CNTA price moves, Exome Asset Management LLC correctly timed 5 out of 5 reported position changes (100%). The annualised alpha on CNTA relative to SPY over the holding period was +80.8%.

← Back to Exome Asset Management LLC Holdings